These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11328661

  • 1. Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport).
    Terasaki T, Pardridge WM.
    J Drug Target; 2000; 8(6):353-5. PubMed ID: 11328661
    [No Abstract] [Full Text] [Related]

  • 2. Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.
    Gynther M, Ropponen J, Laine K, Leppänen J, Haapakoski P, Peura L, Järvinen T, Rautio J.
    J Med Chem; 2009 May 28; 52(10):3348-53. PubMed ID: 19402664
    [Abstract] [Full Text] [Related]

  • 3. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE, Kokjohn TA.
    Alzheimers Dement; 2009 Sep 28; 5(5):437-8. PubMed ID: 19751925
    [No Abstract] [Full Text] [Related]

  • 4. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.
    Hachinski V, Lee TY.
    Alzheimers Dement; 2009 Sep 28; 5(5):435-6. PubMed ID: 19751924
    [No Abstract] [Full Text] [Related]

  • 5. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I, Steinbusch HW, Schmitz C, Martinez-Martinez P, European NanoBioPharmaceutics Research Initiative.
    Prog Neurobiol; 2009 Apr 28; 87(4):212-51. PubMed ID: 19395337
    [Abstract] [Full Text] [Related]

  • 6. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
    Perioli L, Ambrogi V, Bernardini C, Grandolini G, Ricci M, Giovagnoli S, Rossi C.
    Eur J Med Chem; 2004 Aug 28; 39(8):715-27. PubMed ID: 15276305
    [Abstract] [Full Text] [Related]

  • 7. Blood-brain barrier drug targeting: the future of brain drug development.
    Pardridge WM.
    Mol Interv; 2003 Mar 28; 3(2):90-105, 51. PubMed ID: 14993430
    [Abstract] [Full Text] [Related]

  • 8. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ, de Boer AG.
    Methods Mol Biol; 2008 Mar 28; 437():161-75. PubMed ID: 18369968
    [Abstract] [Full Text] [Related]

  • 9. Drug targeting to the brain.
    de Boer AG, Gaillard PJ.
    Annu Rev Pharmacol Toxicol; 2007 Mar 28; 47():323-55. PubMed ID: 16961459
    [Abstract] [Full Text] [Related]

  • 10. Large neutral amino acid transporter enables brain drug delivery via prodrugs.
    Gynther M, Laine K, Ropponen J, Leppänen J, Mannila A, Nevalainen T, Savolainen J, Järvinen T, Rautio J.
    J Med Chem; 2008 Feb 28; 51(4):932-6. PubMed ID: 18217702
    [Abstract] [Full Text] [Related]

  • 11. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha.
    Lee NY, Kang YS.
    Brain Res; 2004 Oct 08; 1023(1):141-7. PubMed ID: 15364029
    [Abstract] [Full Text] [Related]

  • 12. Delivery of therapeutic molecules into the CNS.
    Emborg ME, Kordower JH.
    Prog Brain Res; 2000 Oct 08; 128():323-32. PubMed ID: 11105691
    [No Abstract] [Full Text] [Related]

  • 13. mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting.
    Hosoya KI, Takashima T, Tetsuka K, Nagura T, Ohtsuki S, Takanaga H, Ueda M, Yanai N, Obinata M, Terasaki T.
    J Drug Target; 2000 Oct 08; 8(6):357-70. PubMed ID: 11328662
    [Abstract] [Full Text] [Related]

  • 14. Brain drug targeting: a computational approach for overcoming blood-brain barrier.
    Mehdipour AR, Hamidi M.
    Drug Discov Today; 2009 Nov 08; 14(21-22):1030-6. PubMed ID: 19647097
    [Abstract] [Full Text] [Related]

  • 15. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
    Isakovic AJ, Abbott NJ, Redzic ZB.
    J Neurochem; 2004 Jul 08; 90(2):272-86. PubMed ID: 15228584
    [Abstract] [Full Text] [Related]

  • 16. Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport.
    Yang J, Aschner M.
    Neurotoxicology; 2003 Aug 08; 24(4-5):741-5. PubMed ID: 12900088
    [Abstract] [Full Text] [Related]

  • 17. [Neuropeptides and the hemato-encephalic barrier].
    Mar'ianovich AT, Poliakov EL.
    Usp Fiziol Nauk; 1991 Aug 08; 22(2):33-51. PubMed ID: 1853639
    [No Abstract] [Full Text] [Related]

  • 18. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
    Deeken JF, Löscher W.
    Clin Cancer Res; 2007 Mar 15; 13(6):1663-74. PubMed ID: 17363519
    [Abstract] [Full Text] [Related]

  • 19. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D, Combs-Bachmann RE, Hussey AM, McCarron ST, McCarthy DS, Chambers JJ.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):666-85. PubMed ID: 22138074
    [Abstract] [Full Text] [Related]

  • 20. [Direct drug delivery to the brain].
    Chekhonin VP, Zhirkov IuA, Dmitrieva TB.
    Vestn Ross Akad Med Nauk; 2006 May 15; (8):30-7. PubMed ID: 17002024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.